Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rubicon Genomics Adds European Distributors Ahead of New Product Launches

Published: Saturday, June 14, 2014
Last Updated: Saturday, June 14, 2014
Bookmark and Share
Company has signed agreements with seven distributors to expand the availability of its DNA library preparation products.

Rubicon Genomics, Inc. has announced that it has signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

The new distributors include Cambridge Bioscience in the UK and Ireland, Biozym Scientific GmbH in Germany and Austria, AB ANALITICA in Italy, Sopachem in the Benelux countries, Nordic Biolabs in Denmark and Sweden, Immuno Diagnostic Oy in Finland and YBUX inRomania, the Slovak Republic and the Czech Republic.

James Koziarz, PhD, CEO of Rubicon Genomics, commented, “Our healthy increase in revenues during the past year reflects the early stages of our strategic efforts to aggressively expand our product offerings and build a network of first-rate distributors around the globe. Now that we have our key distribution channels in place, we expect to achieve even greater sales growth going forward, through broader distribution of our recently launched products and the addition of product enhancements in the coming months.”

During the second quarter, Rubicon will launch ThruPLEX DNA-seq 48D kits and ThruPLEX DNA-seq 96D kits. These enhancements of the company’s ThruPLEX FD Prep kits DNA-seq product line offer an increased number of barcodes, which will enable scientists to use ThruPLEX DNA-seq kits for high throughput applications, and reformulated chemistries that provide improved performance. These kits are currently undergoing Beta testing worldwide with samples ranging from cell-free (cf) plasma DNA to human oocyte cDNA, and initial response has been excellent.

The enhanced ThruPLEX DNA-seq products address the needs of clinicians and scientists working in high throughput applications by adding either 48 or 96 dual barcodes to the kit. The chemistry has also been reformulated and demonstrates improved performance that is especially helpful for challenging clinical specimens, such as plasma or FFPE samples, where DNA input amounts are typically low and/or damaged.

ThruPLEX DNA-seq kits streamline library preparation for DNA/cDNA and reduce sample input amounts to picogram levels. The ThruPLEX DNA-seq kit’s patented technology delivers a highly-efficient and user-friendly three-step process that takes place in a single tube in less than two hours, eliminating purifications and speeding time to results. ThruPLEX DNA-seq provides accurate and reproducible results for a variety of applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rubicon Team Up with Curio Genomics
The partnership is set up to provide ultra-fast bioinformatics software designed for use with the new Rubicon ThruPLEX® Tag-seq kits.
Thursday, September 22, 2016
SomaGenics Licenses Rights to Rubicon Genomics
SomaGenics Inc. has licensed rights of its RealSeq-AC Technology to Rubicon Genomics.
Friday, July 29, 2016
Rubicon Genomics Raises $2M
Rubicon Genomics today announced it has secured $2 million in growth capital financing.
Thursday, July 16, 2015
Rubicon Genomics Adds Global Distributors
Sales of Rubicon Genomics’ DNA library prep kit products increase over 50% as expansion of distribution channels continues.
Friday, October 17, 2014
Rubicon Partners with Diagenode for ChIP Sample Preparation
Combining Rubicon ThruPLEX™ and Diagenode technologies enables scientists to efficiently conduct high quality ChIP studies from small samples for NGS and array analysis.
Monday, November 05, 2012
New Data Show Rubicon’s Amplification Technology Enables Genetic and Epigenetic Analyses of Single Cells Using Next-Gen Sequencing
Data show Rubicon’s whole genome and whole Methylome Amplification kits offer key advantages for cancer, stem cell, and embryo studies.
Tuesday, November 02, 2010
Rubicon Genomics’ PicoPlex™ Technology Enables International Clinical Genetic Study of Single Human Cells
PicoPlex technology validated for accurate testing of single human cells to diagnose genetic abnormalities in advance of assisted reproduction.
Thursday, July 01, 2010
bicon Genomics, Inc. Creates Scientific Advisory Board

Friday, May 31, 2002
Rubicon Genomics, Inc. Creates Scientific Advisory Board

Friday, May 31, 2002
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
BGI Sequences Gingko Tree, Revealing Large, Highly Repetitive Genome
Researchers at BGI have sequenced the more than 10-gigabase ginkgo genome to find a high number of repetitive sequences as well as a number of gene clusters that appear to be involved in defense mechanisms.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!